Differences between 3d and vmat in hypofractionated radiation therapy for localized prostate cancer

被引：0
|
作者：
Navarro, I. [1 ]
Correa, R. [1 ]
Roman, A. [1 ]
Otero, A. [1 ]
Fernandez, A. [1 ]
Prieto, P. [1 ]
Garcia, M. J. [1 ]
Garcia, I. [1 ]
Ordonez, R. [1 ]
Jerez, I. [1 ]
Medina, J. A. [1 ]
Gomez, J. [1 ]
机构：
[1] Hosp Virgen Victoria, Radiat Oncol, Malaga, Spain
来源：
RADIOTHERAPY AND ONCOLOGY | 2019年 / 133卷
关键词：
D O I：
10.1016/S0167-8140(19)32002-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-1582
引用
收藏
页码：S854 / S854
页数：1
相关论文
共 50 条
  • [21] Low incidence of fatigue after hypofractionated stereotactic body radiation therapy for localized prostate cancer
    Dash, Chiranjeev
    Demas, Kristina
    Uhm, Sunghae
    Hanscom, Heather N.
    Kim, Joy S.
    Suy, Simeng
    Davis, Kimberly M.
    Sween, Jennifer
    Collins, Sean
    Adams-Campbell, Lucile L.
    FRONTIERS IN ONCOLOGY, 2012, 2
  • [22] 3D conformal radiation therapy for prostate cancer in elderly patients
    Geinitz, H
    Zimmermann, FB
    Thamm, R
    Schumertl, A
    Busch, R
    Molls, M
    RADIOTHERAPY AND ONCOLOGY, 2005, 76 (01) : 27 - 34
  • [23] A pilot study of highly hypofractionated intensity-modulated radiation therapy over 3 weeks for localized prostate cancer
    Nakamura, Kiyonao
    Ikeda, Itaru
    Inokuchi, Haruo
    Takayama, Kenji
    Inoue, Takahiro
    Kamba, Tomomi
    Ogawa, Osamu
    Hiraoka, Masahiro
    Mizowaki, Takashi
    JOURNAL OF RADIATION RESEARCH, 2018, 59 (05) : 656 - 663
  • [24] Systematic review of hypofractionated radiation therapy for prostate cancer
    Zaorsky, Nicholas G.
    Ohri, Nitin
    Showalter, Timothy N.
    Dicker, Adam P.
    Den, Robert B.
    CANCER TREATMENT REVIEWS, 2013, 39 (07) : 728 - 736
  • [25] Dosimetric comparison among cyberknife, helical tomotherapy and VMAT for hypofractionated treatment in localized prostate cancer
    Serra, Marcello
    Ametrano, Gianluca
    Borzillo, Valentina
    Quarto, Maria
    Muto, Matteo
    Di Franco, Rossella
    Federica, Savino
    Loffredo, Filomena
    Paolo, Muto
    MEDICINE, 2020, 99 (50) : E23574
  • [26] Hypofractionated Radiation Therapy Versus Conventional Radiation Therapy in Patients With Intermediate- to High-Risk Localized Prostate Cancer
    Guo, W.
    Gao, X. S.
    Gu, X.
    Ma, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E236 - E237
  • [27] Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer
    Catton, Charles N.
    Lukka, Himu
    Gu, Chu-Shu
    Martin, Jarad M.
    Supiot, Stephane
    Chung, Peter W. M.
    Bauman, Glenn S.
    Bahary, Jean-Paul
    Ahmed, Shahida
    Cheung, Patrick
    Tai, Keen Hun
    Wu, Jackson S.
    Parliament, Matthew B.
    Tsakiridis, Theodoros
    Corbett, Tom B.
    Tang, Colin
    Dayes, Ian S.
    Warde, Padraig
    Craig, Tim K.
    Julian, Jim A.
    Levine, Mark N.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (17) : 1884 - +
  • [28] The Financial Impact of Hypofractionated Radiation for Localized Prostate Cancer in the United States
    Moore, Assaf
    Stav, Ido
    Den, Robert B.
    Gordon, Noa
    Sarfaty, Michal
    Neiman, Victoria
    Rosenbaum, Eli
    Goldstein, Daniel A.
    JOURNAL OF ONCOLOGY, 2019, 2019
  • [29] The cost effectiveness of 3D conformal radiation therapy compared with conventional techniques for patients with clinically localized prostate cancer
    Horwitz, EM
    Hanlon, AL
    Pinover, WH
    Hanks, GE
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (05): : 1219 - 1225
  • [30] Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline
    Morgan, Scott C.
    Hoffman, Karen
    Loblaw, D. Andrew
    Buyyounouski, Mark K.
    Patton, Caroline
    Barocas, Daniel
    Bentzen, Soren
    Chang, Michael
    Efstathiou, Jason
    Greany, Patrick
    Halvorsen, Per
    Koontz, Bridget F.
    Lawton, Colleen
    Leyrer, C. Marc
    Lin, Daniel
    Ray, Michael
    Sandler, Howard
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (34) : 3411 - +
12345